A Phase II trial of 8 weeks of degarelix for prostate volume reduction: Efficacy and hormonal recovery

Autor: Korzeniowski, M.A., Crook, J.M., Bowes, D., Gaztañaga, M., Ots, A., Jazwal, J., Rose, J., Tétreault-Laflamme, A., Pilote, L., Halperin, R., Kim, D., Petrik, D., Araujo, C., Bachand, F.
Zdroj: In Brachytherapy May-June 2018 17(3):530-536
Databáze: ScienceDirect